Date: 2015-11-05
Type of information: Pipeline acquisition
Compound: biodefense program
Company: Xoma (USA - CA) Nanotherapeutics (USA - FL)
Therapeutic area: Infectious diseases
Type agreement: pipeline acquisition
Action mechanism:
Disease:
Details: * On November 5, 2015, Xoma announced it has divested its biodefense program to Nanotherapeutics, a biopharmaceutical company located in Alachua, FL. Nanotherapeutics will extend employment offers to all employees associated with the program and will prosecute related contract awards going forward. Future opportunities for advancement of Xoma\'s anti-botulinum assets will be solicited and conducted by Nanotherapeutics.
Financial terms:
Latest news:
